Cite

HARVARD Citation

    Lam, C. et al. (2016). A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut. 65 (1), pp. 91-99. [Online]. 
  
Back to record